MicroVision executes 1-for-15 reverse split to maintain Nasdaq listing
MicroVision, Inc. will execute a 1-for-15 reverse stock split effective August 1, 2026, to meet Nasdaq Capital Market bid price requirements, with split-adjusted trading commencing August 3, 2026. The Board approved the reduction of authorized shares from 510 million to 150 million following shareholder authorization.

*this image is generated using AI for illustrative purposes only.
MicroVision, Inc. will implement a 1-for-15 reverse stock split effective August 1, 2026, to increase its per-share trading price and satisfy the minimum bid price requirement for continued listing on the Nasdaq Capital Market. The company's common stock will begin trading on a split-adjusted basis at the opening of trading on August 3, 2026, under the existing ticker symbol MVIS. This strategic action aims to support the company's continued Nasdaq listing while allowing management to focus on executing its commercial growth strategy.
The Board of Directors approved the reverse split following authorization by shareholders at the Annual Meeting of Shareholders held on July 10, 2026. As a result of the split, every 15 shares of issued and outstanding common stock will automatically combine into one share. The total number of authorized shares will be reduced from 510 million to 150 million. Fractional shares will not be issued; instead, shareholders entitled to fractional shares will receive their holding rounded up to the nearest whole share.
The reverse split will affect all shareholders uniformly and will not alter any shareholder's proportional ownership interest, except for adjustments resulting from the treatment of fractional shares. The number of shares underlying the company's outstanding equity awards, warrants, and other equity-based securities will be proportionately adjusted, as will the applicable exercise or conversion prices.
Key Details of the Reverse Split
| Detail | Information |
|---|---|
| Split Ratio | 1-for-15 |
| Effective Date | August 1, 2026 |
| Trading Start Date | August 3, 2026 |
| Authorized Share Reduction | 510 million to 150 million |
| Exchange | Nasdaq Capital Market |
| Ticker Symbol | MVIS |
Equiniti is serving as the exchange agent for the transaction. Shareholders holding shares electronically or in book-entry form are not required to take any action. Those holding certificated shares will receive instructions from Equiniti regarding the exchange of their stock certificates. Additional information is available in the definitive proxy statement filed with the Securities and Exchange Commission on June 11, 2026.
How will the reduction in authorized shares impact MicroVision's ability to raise future capital?
What specific commercial growth initiatives will management prioritize now that the Nasdaq listing risk is mitigated?
How might the reverse split affect the stock's liquidity and trading volume in the short term?
































